177 related articles for article (PubMed ID: 15012983)
1. 3-Amino-2-hydroxyamides and related compounds as inhibitors of methionine aminopeptidase-2.
Sheppard GS; Wang J; Kawai M; BaMaung NY; Craig RA; Erickson SA; Lynch L; Patel J; Yang F; Searle XB; Lou P; Park C; Kim KH; Henkin J; Lesniewski R
Bioorg Med Chem Lett; 2004 Feb; 14(4):865-8. PubMed ID: 15012983
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases.
Wang J; Lou P; Henkin J
J Cell Biochem; 2000 Apr; 77(3):465-73. PubMed ID: 10760954
[TBL] [Abstract][Full Text] [Related]
3. Elucidation of the function of type 1 human methionine aminopeptidase during cell cycle progression.
Hu X; Addlagatta A; Lu J; Matthews BW; Liu JO
Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18148-53. PubMed ID: 17114291
[TBL] [Abstract][Full Text] [Related]
4. Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis.
Zhou G; Tsai CW; Liu JO
J Med Chem; 2003 Jul; 46(16):3452-4. PubMed ID: 12877582
[TBL] [Abstract][Full Text] [Related]
5. Highly potent inhibitors of methionine aminopeptidase-2 based on a 1,2,4-triazole pharmacophore.
Marino JP; Fisher PW; Hofmann GA; Kirkpatrick RB; Janson CA; Johnson RK; Ma C; Mattern M; Meek TD; Ryan MD; Schulz C; Smith WW; Tew DG; Tomazek TA; Veber DF; Xiong WC; Yamamoto Y; Yamashita K; Yang G; Thompson SK
J Med Chem; 2007 Aug; 50(16):3777-85. PubMed ID: 17636946
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of beta-amino-alpha-hydroxy amide derivatives as inhibitors of MetAP2 and HUVEC growth.
Sendzik M; Janc JW; Cabuslay R; Honigberg L; Mackman RL; Magill C; Squires N; Waldeck N
Bioorg Med Chem Lett; 2004 Jun; 14(12):3181-4. PubMed ID: 15149671
[TBL] [Abstract][Full Text] [Related]
7. 4-Aryl-1,2,3-triazole: a novel template for a reversible methionine aminopeptidase 2 inhibitor, optimized to inhibit angiogenesis in vivo.
Kallander LS; Lu Q; Chen W; Tomaszek T; Yang G; Tew D; Meek TD; Hofmann GA; Schulz-Pritchard CK; Smith WW; Janson CA; Ryan MD; Zhang GF; Johanson KO; Kirkpatrick RB; Ho TF; Fisher PW; Mattern MR; Johnson RK; Hansbury MJ; Winkler JD; Ward KW; Veber DF; Thompson SK
J Med Chem; 2005 Sep; 48(18):5644-7. PubMed ID: 16134930
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells.
Turk BE; Griffith EC; Wolf S; Biemann K; Chang YH; Liu JO
Chem Biol; 1999 Nov; 6(11):823-33. PubMed ID: 10574784
[TBL] [Abstract][Full Text] [Related]
9. Discovery, identification, and characterization of candidate pharmacodynamic markers of methionine aminopeptidase-2 inhibition.
Warder SE; Tucker LA; McLoughlin SM; Strelitzer TJ; Meuth JL; Zhang Q; Sheppard GS; Richardson PL; Lesniewski R; Davidsen SK; Bell RL; Rogers JC; Wang J
J Proteome Res; 2008 Nov; 7(11):4807-20. PubMed ID: 18828628
[TBL] [Abstract][Full Text] [Related]
10. New thiol and sulfodiimine metalloproteinase inhibitors and their effect on human microvascular endothelial cell growth.
Sang QX; Jia MC; Schwartz MA; Jaye MC; Kleinman HK; Ghaffari MA; Luo YL
Biochem Biophys Res Commun; 2000 Aug; 274(3):780-6. PubMed ID: 10924354
[TBL] [Abstract][Full Text] [Related]
11. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2.
Griffith EC; Su Z; Niwayama S; Ramsay CA; Chang YH; Liu JO
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15183-8. PubMed ID: 9860943
[TBL] [Abstract][Full Text] [Related]
12. Aroyl-pyrrolyl hydroxyamides: influence of pyrrole C4-phenylacetyl substitution on histone deacetylase inhibition.
Mai A; Massa S; Valente S; Simeoni S; Ragno R; Bottoni P; Scatena R; Brosch G
ChemMedChem; 2006 Feb; 1(2):225-37. PubMed ID: 16892355
[TBL] [Abstract][Full Text] [Related]
13. Discovery and optimization of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2: a structural basis for the reduction of albumin binding.
Sheppard GS; Wang J; Kawai M; Fidanze SD; BaMaung NY; Erickson SA; Barnes DM; Tedrow JS; Kolaczkowski L; Vasudevan A; Park DC; Wang GT; Sanders WJ; Mantei RA; Palazzo F; Tucker-Garcia L; Lou P; Zhang Q; Park CH; Kim KH; Petros A; Olejniczak E; Nettesheim D; Hajduk P; Henkin J; Lesniewski R; Davidsen SK; Bell RL
J Med Chem; 2006 Jun; 49(13):3832-49. PubMed ID: 16789740
[TBL] [Abstract][Full Text] [Related]
14. Depletion of methionine aminopeptidase 2 does not alter cell response to fumagillin or bengamides.
Kim S; LaMontagne K; Sabio M; Sharma S; Versace RW; Yusuff N; Phillips PE
Cancer Res; 2004 May; 64(9):2984-7. PubMed ID: 15126329
[TBL] [Abstract][Full Text] [Related]
15. Carbamate analogues of fumagillin as potent, targeted inhibitors of methionine aminopeptidase-2.
Arico-Muendel CC; Benjamin DR; Caiazzo TM; Centrella PA; Contonio BD; Cook CM; Doyle EG; Hannig G; Labenski MT; Searle LL; Lind K; Morgan BA; Olson G; Paradise CL; Self C; Skinner SR; Sluboski B; Svendsen JL; Thompson CD; Westlin W; White KF
J Med Chem; 2009 Dec; 52(24):8047-56. PubMed ID: 19929003
[TBL] [Abstract][Full Text] [Related]
16. Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2.
Wang J; Sheppard GS; Lou P; Kawai M; BaMaung N; Erickson SA; Tucker-Garcia L; Park C; Bouska J; Wang YC; Frost D; Tapang P; Albert DH; Morgan SJ; Morowitz M; Shusterman S; Maris JM; Lesniewski R; Henkin J
Cancer Res; 2003 Nov; 63(22):7861-9. PubMed ID: 14633714
[TBL] [Abstract][Full Text] [Related]
17. Hybrid angiogenesis inhibitors: synthesis and biological evaluation of bifunctional compounds based on 1-deoxynojirimycin and aryl-1,2,3-triazoles.
Zhou Y; Zhao Y; O' Boyle KM; Murphy PV
Bioorg Med Chem Lett; 2008 Feb; 18(3):954-8. PubMed ID: 18166456
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors.
Dublanchet AC; Ducrot P; Andrianjara C; O'Gara M; Morales R; Compère D; Denis A; Blais S; Cluzeau P; Courté K; Hamon J; Moreau F; Prunet ML; Tertre A
Bioorg Med Chem Lett; 2005 Aug; 15(16):3787-90. PubMed ID: 16002291
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships of aryloxyalkanoic acid hydroxyamides as potent inhibitors of histone deacetylase.
Marson CM; Mahadevan T; Dines J; Sengmany S; Morrell JM; Alao JP; Joel SP; Vigushin DM; Charles Coombes R
Bioorg Med Chem Lett; 2007 Jan; 17(1):136-41. PubMed ID: 17046252
[TBL] [Abstract][Full Text] [Related]
20. Structural analysis of bengamide derivatives as inhibitors of methionine aminopeptidases.
Xu W; Lu JP; Ye QZ
J Med Chem; 2012 Sep; 55(18):8021-7. PubMed ID: 22913487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
